Related Experiment Video
Updated: Jun 30, 2025
Author Spotlight: Evaluating Therapeutic Strategies to Enhance Liver Regeneration
Published on: May 24, 2024
Improving survival in alcohol-related hepatitis: what's new?
Jessica Shearer1, Amy Johnson1, Steven Masson1,2
1Liver Unit, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
Insights
Alcohol-related hepatitis (AH) has high mortality, with current treatments focusing on infection screening and steroids. Novel therapies and early liver transplantation (LT) are emerging as promising options for improving patient outcomes.
Area of Science:
- Hepatology and Gastroenterology
- Internal Medicine
- Transplantation Medicine
Background:
- Alcohol-related hepatitis (AH) is a severe manifestation of alcohol-related liver disease, associated with significant short-term and long-term mortality.
- Current therapeutic strategies for AH are limited, underscoring the need for improved management approaches.
- Existing management emphasizes early diagnosis, infection control, and corticosteroid therapy guided by prognostic scores.
Purpose of the Study:
- To review the current evidence for the assessment and treatment of alcohol-related hepatitis.
- To explore emerging novel therapies and the role of early liver transplantation in managing AH.
- To discuss how recent advances are influencing clinical practice and improving outcomes in the UK.
Main Methods:
- Review of current evidence-based guidelines and recent literature on alcohol-related hepatitis management.
- Analysis of prognostic scoring systems for identifying patients eligible for corticosteroid therapy.
- Evaluation of emerging therapeutic options and the expanding role of liver transplantation in selected AH cases.
Main Results:
- Standard management includes early identification, infection screening, and corticosteroid use in appropriate patients.
- Novel therapeutic strategies are under investigation to provide alternative treatment options for AH.
- Early liver transplantation is increasingly recognized as a viable and effective option for select AH patients.
Conclusions:
- Advances in understanding and treating AH are crucial for improving patient survival rates.
- A multi-faceted approach, including novel therapies and timely liver transplantation, is essential for managing severe AH.
- The integration of these advancements into clinical practice holds promise for better outcomes in the UK.
Abstract:
Alcohol-related hepatitis (AH) is the most florid presentation of alcohol-related liver disease and carries a high short-term and long-term mortality rate. Specific treatment options remain inadequate. The current management approach for AH focuses on early identification, careful screening and treatment of infection, as well as identification of those patients who may benefit from corticosteroid therapy based on validated prognostic scoring systems. In recent years, there has been growing interest in exploring novel therapies for AH, which may offer alternative treatment options beyond the traditional approaches. Additionally, early liver transplantation (LT) has emerged as a promising option in selected cases with growing evidence supporting its role. In this review, we will discuss the current evidence base for the assessment and treatment of AH, and how these advances are shaping practice to improve outcomes in the UK.
